查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1624349

细胞治疗市场 - 2024-2034 年全球产业分析、规模、份额、成长、趋势和预测

Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 161 Pages | 商品交期: 2-10个工作天内

价格

细胞治疗市场 - 报告范围

TMR 关于全球细胞治疗市场的报告研究了过去以及当前的成长趋势和机会，以获得 2024 年至 2034 年预测期内市场指标的宝贵见解。 ，考虑2024年为基准年，2034年为预测年。报告中也提供了2024年至2034年全球细胞治疗市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解细胞治疗市场。

市场概况
2023年市场价值 48 亿美元
2034 年市场价值 446 亿美元
复合年增长率 20.8%

该报告深入探讨了全球细胞治疗市场的竞争格局。全球细胞治疗市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球细胞治疗市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2020-2034 年全球市场分析与预测

第 5 章：关键见解

  • 波特五力分析
  • PEST分析
  • 重要行业事件 - 产品批准
  • 重要产业活动 - 伙伴关係与协作

第 6 章：全球市场分析与预测：按类型

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年按类型分類的市场价值预测
    • T-
      • 嵌合抗原受体 (CAR) T 细胞
      • T细胞受体
      • 肿瘤浸润淋巴细胞
    • 干
    • 自然杀手细胞
    • 树突状细胞
    • 其他细胞疗法
  • 按类型分類的市场吸引力

第 7 章：全球市场分析与预测：按产地分类

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年按产地分類的市场价值预测
    • 自体疗法
    • 同种异体疗法
  • 按原产地分類的市场吸引力

第 8 章：全球市场分析与预测：按治疗领域

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年治疗领域市场价值预测
    • 肿瘤疾病
    • 自体免疫疾病
    • 神经系统疾病
    • 其他的
  • 按治疗领域分類的市场吸引力

第 9 章：全球市场分析与预测：按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 按国家/地区分類的市场吸引力

第 10 章：北美市场分析与预测

  • 我们
  • 加拿大

第 11 章：欧洲市场分析与预测

  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区

第 12 章：亚太市场分析与预测

  • 中国
  • 印度
  • 日本
  • 澳洲和纽西兰
  • 亚太地区其他地区

第 13 章：拉丁美洲市场分析与预测

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区

第 14 章：中东和非洲市场分析与预测

  • 海湾合作委员会
  • 南非
  • 中东和非洲其他地区

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 公司市占率分析 (2023)
  • 公司简介
    • Novartis AG
    • Bristol-Myers Squibb Company
    • IOVANCE Biotherapeutics, Inc.
    • Janssen Biotech, Inc.
    • CellTrans, Inc.
    • Gamida Cell Inc.
    • Dendreon Pharmaceuticals LLC
    • Kite Pharma, Inc.
    • Adaptimmune
    • Takeda Pharmaceutical Company Limited
Product Code: TMRGL63273

Cell Therapy Market - Scope of Report

TMR's report on the global cell therapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global cell therapy market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cell therapy market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the cell therapy market.

Market Snapshot
Market Value in 2023US$ 4.8 Bn
Market Value in 2034US$ 44.6 Bn
CAGR20.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cell therapy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global cell therapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cell therapy market.

The report delves into the competitive landscape of the global cell therapy market. Key players operating in the global cell therapy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global cell therapy market profiled in this report.

Key Questions Answered in Global cell therapy Market Report:

  • What is the sales/revenue generated by cell therapy across all regions during the forecast period?
  • What are the opportunities in the global cell therapy market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Cell Therapy Market - Research Objectives and Research Approach

The comprehensive report on the global cell therapy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global cell therapy market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global cell therapy market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Cell Therapy Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Cell Therapy Market Analysis and Forecasts, 2020-2034

5. Key Insights

  • 5.1. Porter's Five Forces Analysis
  • 5.2. PEST Analysis
  • 5.3. Key Industry Events - Product Approvals
  • 5.4. Key Industry Events - Partnerships and Collaborations

6. Global Cell Therapy Market Analysis and Forecasts, By Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Type, 2020-2034
    • 6.3.1. T-cell Therapy
      • 6.3.1.1. Chimeric Antigen Receptor (CAR) T-cells
      • 6.3.1.2. T-cell Receptors
      • 6.3.1.3. Tumor-Infiltrating Lymphocytes
    • 6.3.2. Stem Cell Therapy
    • 6.3.3. Natural Killer Cells
    • 6.3.4. Dendritic Cells
    • 6.3.5. Other Cell Therapies
  • 6.4. Market Attractiveness By Type

7. Global Cell Therapy Market Analysis and Forecasts, By Origin

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Origin, 2020-2034
    • 7.3.1. Autologous Therapies
    • 7.3.2. Allogenic Therapies
  • 7.4. Market Attractiveness By Origin

8. Global Cell Therapy Market Analysis and Forecasts, By Therapeutic Area

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Therapeutic Area, 2020-2034
    • 8.3.1. Oncological Disorders
    • 8.3.2. Autoimmune Disorders
    • 8.3.3. Neurological Disorders
    • 8.3.4. Others
  • 8.4. Market Attractiveness By Therapeutic Area

9. Global Cell Therapy Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Country/Region

10. North America Cell Therapy Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Type, 2020-2034
    • 10.2.1. T-cell Therapy
      • 10.2.1.1. Chimeric Antigen Receptor (CAR) T-cells
      • 10.2.1.2. T-cell Receptors
      • 10.2.1.3. Tumor-Infiltrating Lymphocytes
    • 10.2.2. Stem Cell Therapy
    • 10.2.3. Natural Killer Cells
    • 10.2.4. Dendritic Cells
    • 10.2.5. Other Cell Therapies
  • 10.3. Market Value Forecast By Origin, 2020-2034
    • 10.3.1. Autologous Therapies
    • 10.3.2. Allogenic Therapies
  • 10.4. Market Value Forecast By Therapeutic Area, 2020-2034
    • 10.4.1. Oncological Disorders
    • 10.4.2. Autoimmune Disorders
    • 10.4.3. Neurological Disorders
    • 10.4.4. Others
  • 10.5. Market Value Forecast By Country, 2020-2034
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By Origin
    • 10.6.3. By Therapeutic Area
    • 10.6.4. By Country

11. Europe Cell Therapy Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Type, 2020-2034
    • 11.2.1. T-cell Therapy
      • 11.2.1.1. Chimeric Antigen Receptor (CAR) T-cells
      • 11.2.1.2. T-cell Receptors
      • 11.2.1.3. Tumor-Infiltrating Lymphocytes
    • 11.2.2. Stem Cell Therapy
    • 11.2.3. Natural Killer Cells
    • 11.2.4. Dendritic Cells
    • 11.2.5. Other Cell Therapies
  • 11.3. Market Value Forecast By Origin, 2020-2034
    • 11.3.1. Autologous Therapies
    • 11.3.2. Allogenic Therapies
  • 11.4. Market Value Forecast By Therapeutic Area, 2020-2034
    • 11.4.1. Oncological Disorders
    • 11.4.2. Autoimmune Disorders
    • 11.4.3. Neurological Disorders
    • 11.4.4. Others
  • 11.5. Market Value Forecast By Country/Sub-region, 2020-2034
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By Origin
    • 11.6.3. By Therapeutic Area
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Cell Therapy Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Type, 2020-2034
    • 12.2.1. T-cell Therapy
      • 12.2.1.1. Chimeric Antigen Receptor (CAR) T-cells
      • 12.2.1.2. T-cell Receptors
      • 12.2.1.3. Tumor-Infiltrating Lymphocytes
    • 12.2.2. Stem Cell Therapy
    • 12.2.3. Natural Killer Cells
    • 12.2.4. Dendritic Cells
    • 12.2.5. Other Cell Therapies
  • 12.3. Market Value Forecast By Origin, 2020-2034
    • 12.3.1. Autologous Therapies
    • 12.3.2. Allogenic Therapies
  • 12.4. Market Value Forecast By Therapeutic Area, 2020-2034
    • 12.4.1. Oncological Disorders
    • 12.4.2. Autoimmune Disorders
    • 12.4.3. Neurological Disorders
    • 12.4.4. Others
  • 12.5. Market Value Forecast By Country/Sub-region, 2020-2034
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By Origin
    • 12.6.3. By Therapeutic Area
    • 12.6.4. By Country/Sub-region

13. Latin America Cell Therapy Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Type, 2020-2034
    • 13.2.1. T-cell Therapy
      • 13.2.1.1. Chimeric Antigen Receptor (CAR) T-cells
      • 13.2.1.2. T-cell Receptors
      • 13.2.1.3. Tumor-Infiltrating Lymphocytes
    • 13.2.2. Stem Cell Therapy
    • 13.2.3. Natural Killer Cells
    • 13.2.4. Dendritic Cells
    • 13.2.5. Other Cell Therapies
  • 13.3. Market Value Forecast By Origin, 2020-2034
    • 13.3.1. Autologous Therapies
    • 13.3.2. Allogenic Therapies
  • 13.4. Market Value Forecast By Therapeutic Area, 2020-2034
    • 13.4.1. Oncological Disorders
    • 13.4.2. Autoimmune Disorders
    • 13.4.3. Neurological Disorders
    • 13.4.4. Others
  • 13.5. Market Value Forecast By Country/Sub-region, 2020-2034
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type
    • 13.6.2. By Origin
    • 13.6.3. By Therapeutic Area
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Cell Therapy Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Type, 2020-2034
    • 14.2.1. T-cell Therapy
      • 14.2.1.1. Chimeric Antigen Receptor (CAR) T-cells
      • 14.2.1.2. T-cell Receptors
      • 14.2.1.3. Tumor-Infiltrating Lymphocytes
    • 14.2.2. Stem Cell Therapy
    • 14.2.3. Natural Killer Cells
    • 14.2.4. Dendritic Cells
    • 14.2.5. Other Cell Therapies
  • 14.3. Market Value Forecast By Origin, 2020-2034
    • 14.3.1. Autologous Therapies
    • 14.3.2. Allogenic Therapies
  • 14.4. Market Value Forecast By Therapeutic Area, 2020-2034
    • 14.4.1. Oncological Disorders
    • 14.4.2. Autoimmune Disorders
    • 14.4.3. Neurological Disorders
    • 14.4.4. Others
  • 14.5. Market Value Forecast By Country/Sub-region, 2020-2034
    • 14.5.1. GCC
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Type
    • 14.6.2. By Origin
    • 14.6.3. By Therapeutic Area
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Novartis AG
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Bristol-Myers Squibb Company
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. IOVANCE Biotherapeutics, Inc.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Janssen Biotech, Inc.
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. CellTrans, Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Gamida Cell Inc.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Dendreon Pharmaceuticals LLC
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Kite Pharma, Inc.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Adaptimmune
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Takeda Pharmaceutical Company Limited
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments

Cell Therapy Market

Cell Therapy Industry

Cell Therapy Market Size

Cell Therapy Market Share

Cell Therapy Market Growth

Cell Therapy Market Analysis

Cell Therapy Market Demand

Cell Therapy Market Forecast

Cell Therapy Market Trends

List of Tables

  • Table 01: Global Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 02: Global Cell Therapy Market Value (US$ Mn) Forecast, by T-cell Therapy, 2020-2034
  • Table 03: Global Cell Therapy Market Value (US$ Mn) Forecast, by Origin, 2020-2034
  • Table 04: Global Cell Therapy Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 05: Global Cell Therapy Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 06: North America Cell Therapy Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 07: North America Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 08: North America Cell Therapy Market Value (US$ Mn) Forecast, by T-cell Therapy, 2020-2034
  • Table 09: North America Cell Therapy Market Value (US$ Mn) Forecast, by Origin, 2020-2034
  • Table 10: North America Cell Therapy Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 11: Europe Cell Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 13: Europe Cell Therapy Market Value (US$ Mn) Forecast, by T-cell Therapy, 2020-2034
  • Table 14: Europe Cell Therapy Market Value (US$ Mn) Forecast, by Origin, 2020-2034
  • Table 15: Europe Cell Therapy Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 16: Asia Pacific Cell Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 18: Asia Pacific Cell Therapy Market Value (US$ Mn) Forecast, by T-cell Therapy, 2020-2034
  • Table 19: Asia Pacific Cell Therapy Market Value (US$ Mn) Forecast, by Origin, 2020-2034
  • Table 20: Asia Pacific Cell Therapy Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 21: Latin America Cell Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 23: Latin America Cell Therapy Market Value (US$ Mn) Forecast, by T-cell Therapy, 2020-2034
  • Table 24: Latin America Cell Therapy Market Value (US$ Mn) Forecast, by Origin, 2020-2034
  • Table 25: Latin America Cell Therapy Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034
  • Table 26: Middle East & Africa Cell Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 28: Middle East & Africa Cell Therapy Market Value (US$ Mn) Forecast, by T-cell Therapy, 2020-2034
  • Table 29: Middle East & Africa Cell Therapy Market Value (US$ Mn) Forecast, by Origin, 2020-2034
  • Table 30: Middle East & Africa Cell Therapy Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2034

List of Figures

  • Figure 01: Global Cell Therapy Market Value (US$ Mn) Share Analysis, by Type, 2023 and 2034
  • Figure 02: Global Cell Therapy Market Share Analysis, by Type, 2023
  • Figure 03: Global Cell Therapy Market Share Analysis, by Type, 2034
  • Figure 04: Global Cell Therapy Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 05: Global Cell Therapy Market Value (US$ Mn), by T-cell Therapy, 2020-2034
  • Figure 06: Global Cell Therapy Market Value Share Analysis, by T-cell Therapy, 2024 and 2034
  • Figure 07: Global Cell Therapy Market Value (US$ Mn), by Stem Cell Therapy, 2020-2034
  • Figure 08: Global Cell Therapy Market Value Share Analysis, by Stem Cell Therapy, 2024 and 2034
  • Figure 09: Global Cell Therapy Market Value (US$ Mn), by Natural Killer Cells, 2020-2034
  • Figure 10: Global Cell Therapy Market Value Share Analysis, by Natural Killer Cells, 2024 and 2034
  • Figure 11: Global Cell Therapy Market Value (US$ Mn), by Dendritic Cells, 2020-2034
  • Figure 12: Global Cell Therapy Market Value Share Analysis, by Dendritic Cells, 2024 and 2034
  • Figure 13: Global Cell Therapy Market Value (US$ Mn), by Other Cell Therapies, 2020-2034
  • Figure 14: Global Cell Therapy Market Value Share Analysis, by Other Cell Therapies, 2024 and 2034
  • Figure 15: Global Cell Therapy Market Value (US$ Mn) Share Analysis, by Origin, 2023 and 2034
  • Figure 16: Global Cell Therapy Market Share Analysis, by Origin, 2023
  • Figure 17: Global Cell Therapy Market Share Analysis, by Origin, 2034
  • Figure 18: Global Cell Therapy Market Attractiveness Analysis, by Origin, 2024-2034
  • Figure 19: Global Cell Therapy Market Value (US$ Mn), by Autologous Therapies, 2020-2034
  • Figure 20: Global Cell Therapy Market Value Share Analysis, by Autologous Therapies, 2024 and 2034
  • Figure 21: Global Cell Therapy Market Value (US$ Mn), by Allogenic Therapies, 2020-2034
  • Figure 22: Global Cell Therapy Market Value Share Analysis, by Allogenic Therapies, 2024 and 2034
  • Figure 23: Global Cell Therapy Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 24: Global Cell Therapy Market Share Analysis, by Therapeutic Area, 2023
  • Figure 25: Global Cell Therapy Market Share Analysis, by Therapeutic Area, 2034
  • Figure 26: Global Cell Therapy Market Attractiveness Analysis, by Therapeutic Area, 2024-2034
  • Figure 27: Global Cell Therapy Market Value (US$ Mn), by Oncological Disorders, 2020-2034
  • Figure 28: Global Cell Therapy Market Value Share Analysis, by Oncological Disorders, 2024 and 2034
  • Figure 29: Global Cell Therapy Market Value (US$ Mn), by Autoimmune Disorders, 2020-2034
  • Figure 30: Global Cell Therapy Market Value Share Analysis, by Autoimmune Disorders, 2024 and 2034
  • Figure 31: Global Cell Therapy Market Value (US$ Mn), by Neurological Disorders, 2020-2034
  • Figure 32: Global Cell Therapy Market Value Share Analysis, by Neurological Disorders, 2024 and 2034
  • Figure 33: Global Cell Therapy Market Value (US$ Mn), by Others, 2020-2034
  • Figure 34: Global Cell Therapy Market Value Share Analysis, by Others, 2024 and 2034
  • Figure 35: Global Cell Therapy Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 36: Global Cell Therapy Market Share Analysis, by Region, 2023
  • Figure 37: Global Cell Therapy Market Share Analysis, by Region, 2034
  • Figure 38: Global Cell Therapy Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 39: North America Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 40: North America Cell Therapy Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 41: North America Cell Therapy Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 42: North America Cell Therapy Market Value (US$ Mn) Share Analysis, by Type, 2023 and 2034
  • Figure 43: North America Cell Therapy Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 44: North America Cell Therapy Market Value (US$ Mn) Share Analysis, by Origin, 2023 and 2034
  • Figure 45: North America Cell Therapy Market Share Analysis, by Origin, 2023
  • Figure 46: North America Cell Therapy Market Share Analysis, by Origin, 2034
  • Figure 47: North America Cell Therapy Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 48: North America Cell Therapy Market Share Analysis, by Therapeutic Area, 2023
  • Figure 49: North America Cell Therapy Market Share Analysis, by Therapeutic Area, 2034
  • Figure 50: Europe Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 51: Europe Cell Therapy Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 52: Europe Cell Therapy Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 53: Europe Cell Therapy Market Value (US$ Mn) Share Analysis, by Type, 2023 and 2034
  • Figure 54: Europe Cell Therapy Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 55: Europe Cell Therapy Market Value (US$ Mn) Share Analysis, by Origin, 2023 and 2034
  • Figure 56: Europe Cell Therapy Market Share Analysis, by Origin, 2023
  • Figure 57: Europe Cell Therapy Market Share Analysis, by Origin, 2034
  • Figure 58: Europe Cell Therapy Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 59: Europe Cell Therapy Market Share Analysis, by Therapeutic Area, 2023
  • Figure 60: Europe Cell Therapy Market Share Analysis, by Therapeutic Area, 2034
  • Figure 61: Asia Pacific Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 62: Asia Pacific Cell Therapy Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 63: Asia Pacific Cell Therapy Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 64: Asia Pacific Cell Therapy Market Value (US$ Mn) Share Analysis, by Type, 2023 and 2034
  • Figure 65: Asia Pacific Cell Therapy Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 66: Asia Pacific Cell Therapy Market Value (US$ Mn) Share Analysis, by Origin, 2023 and 2034
  • Figure 67: Asia Pacific Cell Therapy Market Share Analysis, by Origin, 2023
  • Figure 68: North America Cell Therapy Market Share Analysis, by Origin, 2034
  • Figure 69: Asia Pacific Cell Therapy Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 70: Asia Pacific Cell Therapy Market Share Analysis, by Therapeutic Area, 2023
  • Figure 71: Asia Pacific Cell Therapy Market Share Analysis, by Therapeutic Area, 2034
  • Figure 72: Latin America Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 73: Latin America Cell Therapy Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 74: Latin America Cell Therapy Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 75: Latin America Cell Therapy Market Value (US$ Mn) Share Analysis, by Type, 2023 and 2034
  • Figure 76: Latin America Cell Therapy Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 77: Latin America Cell Therapy Market Value (US$ Mn) Share Analysis, by Origin, 2023 and 2034
  • Figure 78: Latin America Cell Therapy Market Attractiveness Analysis, by Origin, 2024-2034
  • Figure 79: Latin America Cell Therapy Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 80: Latin America Cell Therapy Market Attractiveness Analysis, by Therapeutic Area, 2024-2034
  • Figure 81: Middle East & Africa Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 82: Middle East & Africa Cell Therapy Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 83: Middle East & Africa Cell Therapy Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 84: Middle East & Africa Cell Therapy Market Value (US$ Mn) Share Analysis, by Type, 2023 and 2034
  • Figure 85: Middle East & Africa Cell Therapy Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 86: Middle East & Africa Cell Therapy Market Value (US$ Mn) Share Analysis, by Origin, 2023 and 2034
  • Figure 87: Middle East & Africa Cell Therapy Market Attractiveness Analysis, by Origin, 2024-2034
  • Figure 88: Middle East & Africa Cell Therapy Market Value (US$ Mn) Share Analysis, by Therapeutic Area, 2023 and 2034
  • Figure 89: Middle East & Africa Cell Therapy Market Attractiveness Analysis, by Therapeutic Area, 2024-2034